rs114896482
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_004646.4(NPHS1):c.2398C>T(p.Arg800Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000999 in 1,614,076 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R800H) has been classified as Benign.
Frequency
Consequence
NM_004646.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NPHS1 | NM_004646.4 | c.2398C>T | p.Arg800Cys | missense_variant | 18/29 | ENST00000378910.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NPHS1 | ENST00000378910.10 | c.2398C>T | p.Arg800Cys | missense_variant | 18/29 | 1 | NM_004646.4 | P2 | |
NPHS1 | ENST00000353632.6 | c.2398C>T | p.Arg800Cys | missense_variant | 18/28 | 5 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.00153 AC: 232AN: 152094Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00229 AC: 576AN: 251448Hom.: 4 AF XY: 0.00223 AC XY: 303AN XY: 135902
GnomAD4 exome AF: 0.000945 AC: 1381AN: 1461864Hom.: 8 Cov.: 33 AF XY: 0.000899 AC XY: 654AN XY: 727238
GnomAD4 genome ? AF: 0.00152 AC: 232AN: 152212Hom.: 3 Cov.: 32 AF XY: 0.00220 AC XY: 164AN XY: 74416
ClinVar
Submissions by phenotype
Finnish congenital nephrotic syndrome Uncertain:1Benign:3
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 03, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | May 18, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Counsyl | May 08, 2018 | - - |
Familial idiopathic steroid-resistant nephrotic syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Aug 06, 2015 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at